Microbial Bioreactor Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Microbial Bioreactor Market is segmented By Bioreactor Type (Continuous Stirred Tank Bioreactors, Bubble Column Bioreactors, Airlift Bioreactors, Fluidized Bio Reactors, and others), By End-User (Biopharmaceuticals, Food, and Food Additives, Chemicals, R&D institutes, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

The Global Microbial Bioreactor Market is expected to grow at a CAGR of 20.1% during the forecast period (2024-2031)

Micro bioreactors serve as a multitude of scale-down needs for bioprocesses based on mammalian cells. Microbioreactor technology has allowed for rapid advancements in biotechnology process development and investigation of various biological systems from industrial biotechnology and pharmaceutical biotechnology. Micro bioreactors range in complexity from simple micro-tier-based systems to complex automated parallel bioreactors designed for effective scaling up/down of conventional pilot and large-scale bioprocess. Currently, the majority of micro bioreactors are designed for batch and fed-batch processing, many companies are focusing on developing micro bioreactors with continuous chemostat mode operation.

Market Summary

For More Insights about the Market Request Free Sample

Market Dynamics

Increasing demand for miniature bioreactors for research and development of novel technologies for personalized medicine is driving the micro bioreactor market globally during the forecast period. Increasing demand for personalized medicines coupled with a significant rise in the utilization of micro bioreactors for the production of necessary therapies is driving the global micro bioreactor market during the forecast period. The majority of drugs under the pipeline stage by globally dominating companies are related to personalized medicine and biomarkers. It is estimated that 30-40% of the novel drugs in the pipeline are being developed in conjunction with a biomarker making this relevant to the treatment of diseases. Additionally, the increased demand for patient-specific therapies, and cell culture, are contributing to the growth of the microbioreactor market during the forecast period.

However, the availability of alternatives at lower prices and minimal availability in low-economy nations are major factors hindering the growth of the Micro Bioreactor market globally during the forecast period.  

Market Segment Analysis

The global micro bioreactor market is segmented based on application in Biopharmaceutical Industry, Food & Food Additives, Educational Institutions, and others.

Micro-Bioreactors are currently being extensively used by educational and training institutions for imparting technical knowledge to students or professionals through live exposure. The majority of the educational institutions in the medical, pharmaceutical, food technology, and chemical domains are increasingly focusing on developing novel technologies to meet industry requirements for sustainable technologies. The significant rise in investments by the educational institutions towards research activities in targeted medicines, regenerative medicines, and cell culture mediums is boosting huge market demand for micro bioreactors from educational institutions globally during the forecast period.

Market Geographical Share

By region, the global Micro Bioreactor market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa.

Europe is the second most dominant region followed by North America in the global micro bioreactor market owing to the wide presence of pharmaceutical companies and a significant rise in the utilization of micro bioreactors for the production of novel ingredients and drugs for specific/uncured diseases. UK, Germany, and many other countries in Europe are occupying significant market share in the European micro bioreactor market owing to the high presence of research & development laboratories across the globe coupled with a significant rise in investments by the respective companies to boost the development of novel drugs through micro bioreactors. According to the study published in the European Federation of Pharmaceutical Industries and Associations, the R&D expenditure by the pharmaceutical companies located across the European Union increased from USD 38.362 billion in 2017 to USD 41.536 billion in 2018.

Competitive Analysis

The global micro bioreactor market is highly consolidated with very companies operating in the market. The market is currently experiencing huge investments and developments in novel equipment with high performance and output.

In May 2019, Sartorius Stedim Biotech launched a new ambr 15 cell culture microbioreactor system for improved clone selection as well as media and media optimization in fed-batch & perfusion mimic conditions.

Some of the key players in the global micro bioreactor market include m2p-labs GmbH, Sartorius AG, Applikon Biotechnology, Eppendorf AG, Infos AG, and many other regional and global companies.

Why Purchase the Report?

• Visualize the composition of the global micro bioreactor market in terms of type, and application highlighting the key commercial assets and players.
• Identify commercial opportunities in the global micro bioreactor market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of global micro bioreactor market-level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

**The global micro bioreactor report will provide access to approximately 53 market data tables, 43 figures, and 198 pages.

Target Audience

• Investors/Investment Bankers
• Snacks Manufacturers
• Food & Beverages Companies.
• Research Organizations